Answers are grounded in this paper and cite their sources.
Like other steroid hormone receptors, estrogen receptor-α (ERα) is a substrate for protein kinases, and phosphorylation has profound effects on the function and activity of this receptor. A number of different kinases have been implicated in ERα regulation. In this report we show by mutational analysis and in vitro kinase assays that ERα is a substrate for glycogen synthase kinase-3 (GSK-3) in vitro and is phosphorylated on two sites, the Ser-102, -104, and -106 motif and Ser-118, both located in the N-terminal transcription activation function (AF-1) domain. GSK-3 forms a complex with ERα in vivo as demonstrated by co-immunoprecipitation from cell lysates. The GSK-3 inhibitor lithium chloride was used to determine the role of GSK-3 in phosphorylation of Ser-102, -104, and -106 and Ser-118 in vivo and to explore the role of these serines in the regulation of ERα function. Treatment of cells with lithium chloride resulted in dephosphorylation of Ser-104 and -106 and Ser-118, which suggests these serine residues as targets for GSK-3 in vivo. Our results further suggest that ERα phosphorylation by GSK-3 stabilizes ERα under resting conditions and modulates ERα transcriptional activity upon ligand binding. Inhibition and constitutive activation of GSK-3, both, resulted in inhibition of ERα transcriptional activity, indicating a function of active as well as inactive GSK-3 in ERα regulation. These findings uncover a novel mechanism for the regulation of ERα-mediated estrogen signaling controlled by a dual action of GSK-3. Like other steroid hormone receptors, estrogen receptor-α (ERα) is a substrate for protein kinases, and phosphorylation has profound effects on the function and activity of this receptor. A number of different kinases have been implicated in ERα regulation. In this report we show by mutational analysis and in vitro kinase assays that ERα is a substrate for glycogen synthase kinase-3 (GSK-3) in vitro and is phosphorylated on two sites, the Ser-102, -104, and -106 motif and Ser-118, both located in the N-terminal transcription activation function (AF-1) domain. GSK-3 forms a complex with ERα in vivo as demonstrated by co-immunoprecipitation from cell lysates. The GSK-3 inhibitor lithium chloride was used to determine the role of GSK-3 in phosphorylation of Ser-102, -104, and -106 and Ser-118 in vivo and to explore the role of these serines in the regulation of ERα function. Treatment of cells with lithium chloride resulted in dephosphorylation of Ser-104 and -106 and Ser-118, which suggests these serine residues as targets for GSK-3 in vivo. Our results further suggest that ERα phosphorylation by GSK-3 stabilizes ERα under resting conditions and modulates ERα transcriptional activity upon ligand binding. Inhibition and constitutive activation of GSK-3, both, resulted in inhibition of ERα transcriptional activity, indicating a function of active as well as inactive GSK-3 in ERα regulation. These findings uncover a novel mechanism for the regulation of ERα-mediated estrogen signaling controlled by a dual action of GSK-3. Estrogen receptor-α (ERα) 3The abbreviations used are: ERα, estrogen receptor-α; ERE, estrogen response element; GSK-3, glycogen synthase kinase-3; GST, glutathione S-transferase; MEK, mitogen-activated protein kinase kinase or extracellular-regulated kinase kinase; PI3K, phosphatidylinositol 3-kinase; CREB, cAMP-response element-binding protein.3The abbreviations used are: ERα, estrogen receptor-α; ERE, estrogen response element; GSK-3, glycogen synthase kinase-3; GST, glutathione S-transferase; MEK, mitogen-activated protein kinase kinase or extracellular-regulated kinase kinase; PI3K, phosphatidylinositol 3-kinase; CREB, cAMP-response element-binding protein. is a member of the nuclear receptor superfamily of transcription factors, which are activated by small lipid-soluble molecules including steroid hormones (1Mangelsdorf D.J. Thummel C. Beato M. Herrlich P. Schütz G. Umesono K. Blumberg B. Kastner P. Mark M. Chambon P. Evans R.M. Cell. 1995; 83: 835-839Abstract Full Text PDF PubMed Scopus (6062) Google Scholar). Nuclear receptors are characterized by a conserved structural and functional organization and play essential roles in development, differentiation, and metabolism by controlling the expression of specific networks of genes (2Dilworth F.J. Chambon P. Oncogene. 2001; 20: 3047-3054Crossref PubMed Scopus (215) Google Scholar, 3Glass C.K. Rosenfeld M.G. Genes Dev. 2000; 14: 121-141Crossref PubMed Google Scholar). Based on sequence homology and other approaches, the estrogen receptor protein can be divided into six functionally and physically independent domains, nominated A to F (1Mangelsdorf D.J. Thummel C. Beato M. Herrlich P. Schütz G. Umesono K. Blumberg B. Kastner P. Mark M. Chambon P. Evans R.M. Cell. 1995; 83: 835-839Abstract Full Text PDF PubMed Scopus (6062) Google Scholar, 2Dilworth F.J. Chambon P. Oncogene. 2001; 20: 3047-3054Crossref PubMed Scopus (215) Google Scholar), that encode sequences required for DNA binding (region C), nuclear localization (region D), and ligand binding (region E). Ligand binding results in conformational change of ERα, formation of homodimers, translocation into the nucleus, and subsequent binding to estrogen response elements (EREs) located within regulatory regions of target genes (4Tora L. White J.H. Brou C. Tasset D.M. Webster N.J.G. Scheer E. Chambon P. Cell. 1989; 59: 477-487Abstract Full Text PDF PubMed Scopus (889) Google Scholar, 5Tzukerman M.T. Esty A. Santiso-Mere D. Danielian P. Parker M.G. Stein R.B. Pike J.W. McDonnell D.P. Mol. Endocrinol. 1994; 8: 21-30Crossref PubMed Scopus (609) Google Scholar). The ERα has two well characterized transcriptional activation functions: AF-1, which is located in the N-terminal A/B region and may be activated in a ligand-independent manner, and AF-2, which is located in region E and whose activity is ligand-dependent. AF-1 and AF-2 can activate transcription independently and synergistically act in a promoter- and cell type-specific manner (4Tora L. White J.H. Brou C. Tasset D.M. Webster N.J.G. Scheer E. Chambon P. Cell. 1989; 59: 477-487Abstract Full Text PDF PubMed Scopus (889) Google Scholar, 5Tzukerman M.T. Esty A. Santiso-Mere D. Danielian P. Parker M.G. Stein R.B. Pike J.W. McDonnell D.P. Mol. Endocrinol. 1994; 8: 21-30Crossref PubMed Scopus (609) Google Scholar). The ERα, like other members of the steroid hormone receptor superfamily, is phosphorylated on multiple serine residues (6Castano E. Chen C.W. Vorojeikina D.P. Notides A.C. J. Steroid Biochem. Mol. Biol. 1998; 65: 101-110Crossref PubMed Scopus (17) Google Scholar, 7Lannigan D.A. Steroids. 2003; 68: 1-9Crossref PubMed Scopus (386) Google Scholar). Serine phosphorylation is essential for transcriptional activation in response to estradiol binding and occurs on Ser-167 and Ser-118, the latter being the major phosphorylation site required for full activation of ERα and to a lesser extent on Ser-104 and Ser-106, all located in the AF-1 domain of the receptor (7Lannigan D.A. Steroids. 2003; 68: 1-9Crossref PubMed Scopus (386) Google Scholar). TFIIH kinase Cdk7 (8Chen D. Riedl T. Washbrook E. Pace P.E. Coombes R.C. Egly J.M. Ali S. Mol. Cell. 2000; 6: 127-137Abstract Full Text Full Text PDF PubMed Scopus (249) Google Scholar) and mitogen-activated protein kinase (9Kato S. Endoh H. Masuhiro Y. Kitamoto T. Uchiyama S. Sasaki H. Masushige S. Gotoh Y. Nishida E. Kawashima H. Metzger D. Chambon P. Science. 1995; 270: 1491-1494Crossref PubMed Scopus (1709) Google Scholar) have been reported to phosphorylate Ser-118, and cyclin A-Cdk2 was associated with Ser-104 and -106 phosphorylation (10Rogatzki I. Trowbridge J.M. Garabedian M.J. J. Biol. Chem. 1999; 274: 22296-22302Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar). Recent work suggested a role of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway in estrogen-dependent activation and nuclear translocation of ERα (11Campbell R.A. Poornima B.N. Patel N.M. Constantinidou S.A. Nakshatri H. J. Biol. Chem. 2001; 276: 9817-9824Abstract Full Text Full Text PDF PubMed Scopus (812) Google Scholar, 12Castoria G. Migliaccio A. Bilancio A. DiDomenico M. DeFalco A. Lombardi M. Fiorentino R. Varricchio L. Barone M.V. Auricchio F. EMBO J. 2001; 20: 6050-6059Crossref PubMed Scopus (399) Google Scholar, 13Stoica G.E. Franke T.F. Moroni M. Mueller S. Morgan E. Iann M.C. Winder A.D. Reiter R. Wellstein A. Martin M.B. Stoica A. Oncogene. 2003; 22: 7998-8011Crossref PubMed Scopus (152) Google Scholar). A protein kinase that has been observed to interact with ERα in rat hippocampus (14Cardona-Gomez P. Perez M. Avila J. Garcia-Segura L.M. Wandosell F. Mol. Cell. Neurosci. 2004; 25: 363-373Crossref PubMed Scopus (170) Google Scholar) and, therefore, may be related to estrogen signaling is glycogen synthase kinase-3 (GSK-3). GSK-3 is a proline-directed serine/threonine kinase (15Woodgett J.R. Methods Enzymol. 1991; 200: 564-577Crossref PubMed Scopus (109) Google Scholar) that is widely expressed in mammalian tissues. Unlike most kinases, GSK-3 is catalytically active in resting cells (16Jope R.S. Johnson G.V.W. Trends Biochem. Sci. 2004; 29: 95-102Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar, 17Frame S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1274) Google Scholar). GSK-3 is a crucial regulator of as well as of in as glycogen and and is implicated in including and (16Jope R.S. Johnson G.V.W. Trends Biochem. Sci. 2004; 29: 95-102Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar). The two mammalian GSK-3 and are controlled in response to or by protein complex and (16Jope R.S. Johnson G.V.W. Trends Biochem. Sci. 2004; 29: 95-102Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar, 17Frame S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1274) Google Scholar, S. Cohen P. R.M. Mol. Cell. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). GSK-3 have a substrate the of the in results in indicating that the of J. J.R. 2000; PubMed Scopus Google Scholar). GSK-3 activity is by phosphorylation on in and in in different cells suggest that the protein kinases kinase protein kinase and protein kinase phosphorylate in and in S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1274) Google Scholar, K. J.R. Parker J. Biol. Chem. Full Text PDF PubMed Google Scholar, D.A. Cohen P. M. 1995; PubMed Scopus Google Scholar). show that ERα is a substrate of GSK-3, being phosphorylated two different in the AF-1 domain in response to estradiol suggests function of GSK-3 in the regulation of ERα transcriptional and and cells in A. M. Auricchio F. Oncogene. 8: Google Scholar) for with or of cells by cells by the R.S. Methods Enzymol. PubMed Scopus Google Scholar). cells to DNA and in to the cells for by the of and for the was and in was for by and cells in and to the of all cell was by a protein to ERα was from to ERα and to cyclin from and and from was from and and from was from and was from was from and and from from cells on to in with for and with for in for and for and for of GSK-3 and ERα was a the of ERα, and was with a in for was used as to GSK-3, and was used to The of and a and a analysis was the was from the and inhibitor by of with to protein for and with the specific and protein with The to and and by the the with to the in Nuclear the a the was The was in Nuclear in Nuclear and on for and for The and the to and from P. was into The was by the as a and the was into The of ERα was into of the ERα to was the from by DNA sequence analysis the and DNA of for of the domain of and ERα by from the The and into the of with the or the for and with for as by the In ERα or and with for in a of of protein kinase of by and cells with and and in cell assays the from to the and a GSK-3 in ERα on findings that estradiol of cells resulted in activation of kinase in estrogen-dependent cells G. Migliaccio A. Bilancio A. DiDomenico M. DeFalco A. Lombardi M. Fiorentino R. Varricchio L. Barone M.V. Auricchio F. EMBO J. 2001; 20: 6050-6059Crossref PubMed Scopus (399) Google Scholar), and D. we that GSK-3, a substrate and of kinase is in the regulation of ERα function. the role of GSK-3 in transcriptional activation of cells from cells by with a under the of estrogen response the P. E. 2001; PubMed Scopus Google with and with the GSK-3 inhibitor L. J.R. Biol. 6: Full Text Full Text PDF PubMed Google Scholar), and activity was resulted in a of was by the specific for and by The of estrogen-dependent ERα transcriptional activation by a function of active GSK-3 in ERα of cells in GSK-3 phosphorylation in a and manner that with findings on of GSK-3 by in rat hippocampus (14Cardona-Gomez P. Perez M. Avila J. Garcia-Segura L.M. Wandosell F. Mol. Cell. Neurosci. 2004; 25: 363-373Crossref PubMed Scopus (170) Google Scholar). These on GSK-3 by and the in ERα transcriptional activation by the GSK-3 inhibitor and the results the of multiple of GSK-3 ERα GSK-3 with has been reported as a kinase R.M. Biochem. J. 2003; PubMed Scopus Google Scholar), to with in different ERα is a substrate for GSK-3, we ERα and GSK-3 can physically in vivo. The GSK-3 and ERα was by of or ERα and the for the of ERα or observed of GSK-3 and ERα in cells that a A and was by and two different results of ERα and GSK-3 was observed in the of cells and in the in that with ERα was phosphorylated that ERα with the active of therefore, in the of GSK-3 observed on ERα suggest that a small and specific of GSK-3 in the cell is phosphorylated a specific on the of GSK-3 (16Jope R.S. Johnson G.V.W. Trends Biochem. Sci. 2004; 29: 95-102Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar). the site of GSK-3 phosphorylation under we cells resulted in a phosphorylation of GSK-3, GSK-3 located in the of of and ERα was observed ERα into the with nuclear which was in the is that ERα forms with active in both and The ERα domain the GSK-3 and ERα was by the and F of the receptor of the with in all ERα with that the the domain of ERα as the domain with GSK-3 GSK-3 ERα in of active GSK-3 with ERα in cells and of ERα and expressed in cells suggested ERα to a substrate for GSK-3 as a was by a in vitro kinase ERα and in which a phosphorylation of ERα was we the serine residues of ERα that are phosphorylated by GSK-3. has been reported that GSK-3 two different substrate characterized by or phosphorylation S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1274) Google Scholar). of GSK-3 are phosphorylated by kinase a site that is located to the target which the substrate for phosphorylation by GSK-3. motif and are phosphorylated and is in regions of as glycogen synthase Y. J. Biol. Chem. Full Text PDF PubMed Google Scholar), J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar), and C. Y. M. C. Y. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar) the of GSK-3 to be GSK-3 of are cyclin M. Genes Dev. 1998; PubMed Scopus Google Scholar), A. D. R. J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar) and the sequence of the ERα domain and GSK-3 and two GSK-3 phosphorylation in the ERα the motif Ser-102, -104, and -106 and the phosphorylated by GSK-3, we a of phosphorylation ERα in which the serine residues and to and a in which the serines and all by further the residues of the ERα and the different ERα of in vitro kinase assays we for to phosphorylate these of the was with the phosphorylation of the and was with the of and phosphorylation a in the indicating that is phosphorylated Ser-104 is phosphorylation a phosphorylation from the to the of the protein that is for GSK-3. The findings are in with a that the of phosphorylation with of Ser-104 and in the ERα P. D.J. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). the phosphorylated and to a the and in with the and the is for Ser-118 phosphorylation D.A. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar), indicating that Ser-118 can be phosphorylated in these by The in observed with the with the phosphorylation of the observed in with the and can be by Ser-118 phosphorylation as other serines or that be phosphorylated in this was in which Ser-102, Ser-106, and Ser-118 all by and which was that other residues of the ERα domain are phosphorylated by we the of the GSK-3 phosphorylation on ERα transcriptional activity in vivo. of ERα the different in cells resulted in of activity results of cells with the ERα of of the serine residues resulted in of ERα activity, which that all serine residues as GSK-3 phosphorylation in vitro required for full transcriptional activation of ERα in vivo. with the findings of other different cell (6Castano E. Chen C.W. Vorojeikina D.P. Notides A.C. J. Steroid Biochem. Mol. Biol. 1998; 65: 101-110Crossref PubMed Scopus (17) Google Scholar, S. Endoh H. Masuhiro Y. Kitamoto T. Uchiyama S. Sasaki H. Masushige S. Gotoh Y. Nishida E. Kawashima H. Metzger D. Chambon P. Science. 1995; 270: 1491-1494Crossref PubMed Scopus (1709) Google Scholar). ERα by GSK-3 in phosphorylation of the serine which been as the GSK-3 phosphorylation in was in of cells by specific to ERα phosphorylated Ser-118 or Ser-104 and Ser-104 and -106 phosphorylated in cells resulted in a of phosphorylation of Ser-104 and -106 within a in Ser-118 phosphorylation was These that the function of the Ser-102, -104, and -106 motif in ERα is different from that of The of GSK-3 in the phosphorylation of Ser-104 and -106 and Ser-118 of ERα in vivo was by the GSK-3 inhibitor Treatment of cells with resulted in inhibition of Ser-118 phosphorylation and in of Ser-104 and -106 phosphorylation in both cells and in cells on the Ser-118 phosphorylation by GSK-3 upon the other the Ser-104 and -106 site by in cells with that GSK-3 ERα in results cells The effects of on phosphorylation of cyclin and two well GSK-3 C. Y. M. C. Y. Cell. Full Text Full Text PDF PubMed Scopus Google Scholar, M. Genes Dev. 1998; PubMed Scopus Google Scholar) and transcription factors, for in the cell as used for of ERα Treatment with a of phosphorylation of both GSK-3 Our the that the two serine in the ERα AF-1 domain are by GSK-3, which suggests a dual function of GSK-3 in the regulation of ERα GSK-3 may be by multiple signaling including the pathway and the extracellular-regulated kinase The of these in phosphorylation of GSK-3 was by of the cells with the inhibitor and the inhibitor phosphorylation was by to a extent by suggests a role of and the kinase pathway in the of extracellular-regulated kinase and to Ser-118 phosphorylation of ERα, we Ser-118 phosphorylation in the lysates. inhibition of Ser-118 phosphorylation by by for Ser-118 phosphorylation by a nuclear of GSK-3. of cells with resulted in of ERα protein that of the protein may be to dephosphorylation of Ser-102, -104, and -106 as a of GSK-3 was by of with ERα or with the ERα which be phosphorylated in observed a of the ERα protein of to in Ser-118 of phosphorylation of Ser-104 and -106 and Ser-118 in suggests that dephosphorylation of Ser-104 and -106 is a for ERα phosphorylation on therefore, the of GSK-3 observed in cells and and is a to dephosphorylation of Ser-104 and -106 and phosphorylation of A of that be was in with Ser-104 and -106 and Ser-118 was phosphorylated in these cells the expression of this resulted in the of transcriptional activation of ERα by is that of GSK-3 is for ERα The results from these show that both active and inactive GSK-3 are required for the regulation of ERα function. of a of GSK-3 in ERα a for the regulation of ERα activation GSK-3 ERα Ser-104 and -106 and in these conditions the of GSK-3 and ERα stabilizes the ERα in the binding to ERα phosphorylation of GSK-3 by activation of the kinase pathway and of ERα from GSK-3. of the ERα from GSK-3 dephosphorylation Ser-102, -104, and which results in nuclear translocation and in a conformational change of ERα, of Ser-118 to phosphorylation by protein most a nuclear of active GSK-3. In this report we ERα as a GSK-3 substrate that is phosphorylated serine residues located within two different in the AF-1 domain of the receptor. demonstrated functional GSK-3 activity and ERα activation and that GSK-3 modulates ERα function by phosphorylation of serine The serine residues and of ERα, as targets for GSK-3 in this have been to roles in ERα Ser-118 the major site phosphorylated in response to estradiol D.A. Mol. Endocrinol. 1995; Scholar). the protein kinases that phosphorylate Ser-118 in vivo. A phosphorylation on Ser-118 in ERα expressed in cells by mitogen-activated protein kinase (9Kato S. Endoh H. Masuhiro Y. Kitamoto T. Uchiyama S. Sasaki H. Masushige S. Gotoh Y. Nishida E. Kawashima H. Metzger D. Chambon P. Science. 1995; 270: 1491-1494Crossref PubMed Scopus (1709) Google Scholar) with a report that Ser-118 is phosphorylated upon ligand binding to the receptor in a manner D.A. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). The latter Ser-118 phosphorylation by mitogen-activated protein kinase in cells and a active protein kinase to phosphorylate this that with results in activation of mitogen-activated protein kinase in cells and cells C. G. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, K. E. S.A. J. Biochem. 2003; 270: PubMed Scopus Google Scholar) in inhibition of ERα Ser-118 phosphorylation in cells further suggest that other protein kinases may phosphorylate Ser-118 in vivo. Ser-118 is by a of ERα, and this motif may a substrate motif for GSK-3. suggest Ser-118 as a target of GSK-3 by mutational and functional of Ser-118 to resulted in a in phosphorylation in in vitro kinase and most in that is to Ser-118 phosphorylation D.A. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar) was observed in in vitro kinase assays of other serine Ser-118 phosphorylation in which was observed in was by the most used GSK-3 inhibitor by the inhibitor the of Ser-118 phosphorylation with that of ERα and GSK-3 Ser-102, and ERα sequence analysis suggested that Ser-104 and Ser-106, both by GSK-3 phosphorylation is from a target for GSK-3 is phosphorylation on ERα in this report has been reported suggested phosphorylation of other serine residues in the of Ser-104 and P. D.J. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar). GSK-3 and a target for a work that phosphorylation is a is of the as is the for Ser-106, and GSK-3 forms with substrate P. E. M. F. E. F. D. J. A. Mol. Cell. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), as is the for by may a motif for phosphorylation by GSK-3. is by the phosphorylation in in vitro kinase assays the and by the that is in cells with the GSK-3 inhibitor The is for The phosphorylation of Ser-102, Ser-106, and Ser-118 by GSK-3 in this suggests phosphorylation of these serines may be may be to the action of a with the by (7Lannigan D.A. Steroids. 2003; 68: 1-9Crossref PubMed Scopus (386) Google Scholar) that phosphorylation of Ser-118 to be from that of Ser-104 and and that phosphorylation may be to the action of a GSK-3 and a number of transcription in a J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar), K. C. I. A. Y. M. Mol. 2000; PubMed Scopus Google Scholar), P. L. J. Chen R.S. J. Biol. Chem. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, Biol. 2001; PubMed Scopus Google Scholar), and J. J.R. 2000; PubMed Scopus Google or in a manner J. M. P. Oncogene. 8: Google Scholar), 17Frame S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1274) Google Scholar), receptor I. Garabedian M.J. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar), and receptor J. F. P. G. A. Chen L. M. J. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, L. S. L. C. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, M. Y. H. J. R.M. Oncogene. 2004; PubMed Scopus Google A dual function of GSK-3 has been suggested phosphorylation two different results in or in F. C. P. C. J. Biol. Chem. 2003; Full Text Full Text PDF Scopus Google Scholar). Our suggest a role of GSK-3 as a protein kinase that modulates ERα show that Ser-102, and are and independently from Ser-118 by GSK-3, to different regulatory of the two phosphorylation Ser-104 and phosphorylation is constitutive in cells under that this is for Ser-102, be demonstrated in cell of of a specific the that Ser-102, and have a role in ERα transcriptional of these serine residues to to the of ERα essential for estradiol binding and, therefore, the in ERα Inhibition of constitutive ERα phosphorylation by resulted in of ERα protein which suggests that ERα phosphorylated Ser-102, -104, and -106 is to GSK-3 and the of a function of GSK-3 on ERα protein. of Ser-102, and is a to Ser-118 which is the function of GSK-3 in ERα The of ERα activity observed by of of these serine residues the that the of ERα, which is by these is of for the sequence of phosphorylation of the two regulatory by GSK-3. formation with is a of GSK-3 which that a specific of GSK-3 related to a specific signaling pathway is activated or upon a specific GSK-3 to signaling is by to the and R.S. Johnson G.V.W. Trends Biochem. Sci. 2004; 29: 95-102Abstract Full Text Full Text PDF PubMed Scopus (1324) Google Scholar) of GSK-3 Our show that of GSK-3 with the substrate ERα may both in the and in The different phosphorylation of GSK-3 observed in and that the is in different which to the complex regulation of GSK-3. Our show that phosphorylation of can be by the inhibitor which suggests a role of the pathway in ERα activation in The mechanism in activation of is is to that to a of ERα has been suggested to effects on cell signaling J. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). A of ERα has been to the in cells B. A. S. D. Oncogene. PubMed Scopus Google Scholar). binding to ERα results in a activation of the pathway T. A. D.P. K. 2000; PubMed Scopus Google Scholar), which in may in the phosphorylation of the of which is to ERα and, nuclear ERα GSK-3 has a function in ligand-independent activation of ERα by as which activate the protein kinase pathway and in ERα phosphorylation Ser-118 D.A. Mol. Endocrinol. 1995; Scholar, B. A. S. D. Oncogene. PubMed Scopus Google Scholar). from that GSK-3 is phosphorylated by protein kinase B. A. S. D. Oncogene. PubMed Scopus Google Scholar), that phosphorylation and of GSK-3 as a kinase by specific signaling a mechanism of the regulation of ERα function. P. for GSK-3 and H. and E. for and in that we have with
No takes yet. Share an insight, caveat, or question.
Medunjanin et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: